Urology · Milwaukee, WI
NPI
1124015961
Since 2005
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2311 N Prospect Ave
Milwaukee, WI, 53211
Phone (414) 319-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
730 services
Medicare patients, 2024
352
Average age 76
Drug cost, 2024
$110K
2,464 prescriptions
Company payments, 2025
$554
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Sandock was code 99214 (office e&m - established), 312 times for 228 patients. In total David S Sandock billed 730 services in 44 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 312 | 228 | $69.18 | $22K |
| 52000 Cystourethroscopy | Office | 76 | 59 | $95.94 | $7,291 |
| 99213 Office E&M - Established | Office | 74 | 66 | $49.46 | $3,660 |
| 99204 Office E&M - New | Office | 33 | 33 | $83.59 | $2,759 |
| 51798 Ultrasound - Nonspecific | Office | 29 | 22 | $7.16 | $208 |
| 81003 Clinical Chemistry | Office | 25 | 21 | $2.20 | $55 |
| 52332 Cystourethroscopy | Facility | 19 | 13 | $83.51 | $1,587 |
| 99203 Office E&M - New | Office | 17 | 17 | $48.03 | $816 |
By year: 2022 $60K for 779 services; 2023 $62K for 838 services; 2024 $56K for 730 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 25 | 21 | $2.20 | $55 |
Medicare prescription drug claims, 2024
In 2024, the drug David S Sandock prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 794 prescriptions and refills. In total David S Sandock wrote 2,464 Medicare prescriptions that cost $110K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 794 | 2,105 | 263 | $23K |
| Finasteride Generic | 585 | 1,608 | 195 | $7,363 |
| Tamsulosin Hcl Generic | 434 | 1,196 | 161 | $6,232 |
| Doxazosin Mesylate Generic | 107 | 282 | 34 | $1,461 |
| Solifenacin Succinate Generic | 106 | 264 | 37 | $7,528 |
| Dutasteride Generic | 101 | 235 | 28 | $3,120 |
| Myrbetriq Mirabegron | 53 | 106 | 17 | $47K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 47 | 129 | 20 | $783 |
| Ciprofloxacin Hcl Generic | 31 | 31 | 26 | $126 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 31 | 19 | $165 |
| Terazosin Hcl Generic | 21 | 55 | 11 | $185 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 20 | 20 | 17 | $64.1 |
| Cephalexin Generic | 18 | 18 | 17 | $59.12 |
| Bicalutamide Generic | 13 | 23 | Under 11 | $369 |
| Doxycycline Monohydrate Generic | 11 | 11 | Under 11 | $236 |
Brand drugs: - claims; generic drugs: 2,403 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Sandock $554 ($554 in general payments such as food, travel and fees) from 4 companies. The largest payer was Teleflex LLC with $191.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 1 | $191 |
| Calyxo, Inc. | 1 | $179 |
| Bioprotect Medical, Inc. | 1 | $155 |
| Caris MPI, Inc. | 1 | $29.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.